RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMTX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in immatics biotechnologies GmbH stock price on Friday which ended trading at $11.70
(Updated on May 24, 2024)

Buy candidate since May 24, 2024 PDF

The immatics biotechnologies GmbH stock price gained 19.14% on the last trading day (Friday, 24th May 2024), rising from $9.82 to $11.70. During the last trading day the stock fluctuated 20.47% from a day low at $9.82 to a day high of $11.83. The price has fallen in 6 of the last 10 days but is still up by 8.03% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $25.26 million.

Given the current short-term trend, the stock is expected to fall -14.52% during the next 3 months and, with a 90% probability hold a price between $7.79 and $10.00 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMTX Signals & Forecast

The immatics biotechnologies GmbH stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.74 and $10.60. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 19.63%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for immatics biotechnologies GmbH stock

immatics biotechnologies GmbH finds support from accumulated volume at $11.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.01 between high and low, or 20.47%. For the last week, the stock has had daily average volatility of 7.43%.

Our recommended stop-loss: $11.26 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 59 days ago.)

Trading Expectations (IMTX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect immatics biotechnologies GmbH to open at $11.12, and during the day (based on 14 day Average True Range), to move between $11.09 and $12.31, which gives a possible trading interval of +/-$0.609 (+/-5.21%) up or down from last closing price. If immatics biotechnologies GmbH takes out the full calculated possible swing range there will be an estimated 10.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.60 (0.85%) than the resistance at $12.00 (2.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is immatics biotechnologies GmbH stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Buy candidate.

Current score: 3.639 Buy Candidate Upgraded

Predicted Opening Price for immatics biotechnologies GmbH of Tuesday, May 28, 2024

Fair opening price May 28, 2024 Current price
$11.12 ( 4.99%) $11.70

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.13 12.19 %
R2 12.36 5.63 %
R1 11.88 1.58 %
Current price: 11.70
Support S1 10.35 -11.55 %
S2 9.87 -15.60 %
S3 9.11 -22.17 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12.51 6.92 %
R2 12.27 4.87 %
R1 12.00 2.56 %
Current price 11.70
Support S1 11.60 -0.85%
S2 11.08 -5.30%
S3 10.81 -7.61%

FAQ

What is the symbol for immatics biotechnologies GmbH Stock and on which exchange is it traded?
The symbol for immatics biotechnologies GmbH is IMTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell immatics biotechnologies GmbH Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Buy candidate.

How to buy immatics biotechnologies GmbH Stock?
immatics biotechnologies GmbH Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy immatics biotechnologies GmbH Stock.

What's the current price of immatics biotechnologies GmbH Stock?
As of the end of day on the May 24, 2024, the price of an immatics biotechnologies GmbH (IMTX) share was $11.70.

What is the 52-week high and low for immatics biotechnologies GmbH Stock?
The 52-week high for immatics biotechnologies GmbH Stock is $13.16 and the 52-week low is $7.16.

What is the market capitalization of immatics biotechnologies GmbH Stock?
As of the May 24, 2024, the market capitalization of immatics biotechnologies GmbH is 1.205B.

When is the next earnings date for immatics biotechnologies GmbH?
The upcoming earnings date for immatics biotechnologies GmbH is Aug 15, 2024.
Click to get the best stock tips daily for free!

About immatics biotechnologies GmbH

immatics biotechnologies GmbH Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I ... IMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT